当前位置：
X-MOL 学术
›
J. Antimicrob. Chemother.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Adequate plasma levels of dolutegravir in combination with ritonavir-boosted darunavir: a pharmacokinetic subgroup analysis of the DUALIS study.
Journal of Antimicrobial Chemotherapy ( IF 5.2 ) Pub Date : 2020-07-07 , DOI: 10.1093/jac/dkaa234 Simon Weidlich 1 , Christoph Boesecke 2 , Jochen Schneider 1 , Hartwig H F Klinker 3 , Alexander Zink 4 , Annamaria Balogh 5 , Eva Wolf 5 , Helen Bidner 6 , Christoph D Spinner 1 ,
Journal of Antimicrobial Chemotherapy ( IF 5.2 ) Pub Date : 2020-07-07 , DOI: 10.1093/jac/dkaa234 Simon Weidlich 1 , Christoph Boesecke 2 , Jochen Schneider 1 , Hartwig H F Klinker 3 , Alexander Zink 4 , Annamaria Balogh 5 , Eva Wolf 5 , Helen Bidner 6 , Christoph D Spinner 1 ,
Affiliation
Sir,
中文翻译：
结合dolutegravir和ritonavir增强的darunavir的适当血浆水平：DUALIS研究的药代动力学亚组分析。
先生，
更新日期：2020-07-07
中文翻译：
结合dolutegravir和ritonavir增强的darunavir的适当血浆水平：DUALIS研究的药代动力学亚组分析。
先生，
京公网安备 11010802027423号